Can elevated thyroid peroxidase (TPO) antibodies alone cause urticaria (hives)?

Can Elevated TPO Antibodies Alone Cause Hives?

Elevated TPO antibodies alone do not directly cause hives, but they serve as a biomarker for autoimmune chronic spontaneous urticaria (CSU), where IgG anti-TPO antibodies (not just elevated TPO antibodies) are part of an autoimmune mechanism that triggers mast cell activation and urticaria.

Understanding the Mechanism

The relationship between thyroid antibodies and urticaria is more nuanced than simple causation. According to the 2022 international urticaria guidelines, IgG anti-thyroid peroxidase (anti-TPO) antibodies are recommended as part of basic diagnostic testing for CSU 1. However, the guidelines clarify that these antibodies indicate a specific subtype of urticaria rather than being a direct cause themselves.

Key Distinctions:

• IgG anti-TPO antibodies (not just "elevated TPO antibodies") are associated with type IIb autoimmune CSU, where mast cell-directed activating IgG autoantibodies trigger skin mast cell activation 1

• The high ratio of IgG anti-TPO to total IgE is currently the best surrogate marker for autoimmune CSU 1, with patients showing low or very low total IgE levels and elevated IgG anti-TPO levels 1

• Research demonstrates that IgE antibodies against TPO (not IgG) can directly activate basophils and induce skin reactions in some CSU patients 2, 3, suggesting a pathogenic role in effector cell activation

Clinical Evidence

The association is well-established but complex:

• Meta-analysis shows patients with chronic urticaria have a 5-7 fold higher risk of TPO antibody positivity compared to controls 4

• 51.2% of CSU patients had elevated anti-TPO antibodies versus only 6% in controls, with similar findings for anti-thyroglobulin antibodies 5

• However, anti-TPO IgE is not a specific biomarker for CSU - it appears in healthy subjects (8.1%), autoimmune thyroid disease patients (16.6%), and CSU patients (34.0%) 3

Important Caveat:

The presence of anti-TPO antibodies combined with low total IgE (aTPO↑IgE↓) identifies a specific subset of patients with:

• Higher disease activity and poor antihistamine response (30% response rate vs 47% in those without this pattern) 6
• 44% positive basophil activation test (the best single marker for autoimmune CSU) versus 12% without this pattern 6
• Increased likelihood of angioedema and female predominance 6

Clinical Implications

When evaluating a patient with chronic urticaria:

1. Test for IgG anti-TPO levels AND total IgE as part of basic diagnostic workup 1

2. Calculate the ratio of IgG anti-TPO to total IgE - a high ratio suggests autoimmune CSU 1

3. Patients with elevated anti-TPO and low IgE (aTPO↑IgE↓) pattern:

   • Expect poorer response to standard antihistamine therapy 6
   • Consider earlier escalation to omalizumab (300mg every 4 weeks, up to 600mg every 2 weeks if needed) 1
   • May require third-line cyclosporine (up to 5mg/kg body weight) 1

4. Some euthyroid patients with chronic urticaria and thyroid autoimmunity may benefit from thyroid hormone suppression therapy, with clinical remission reported in patients with elevated anti-thyroid antibodies 7, 8

Common Pitfall:

Do not assume that simply having "elevated TPO antibodies" means they are causing the hives. The mechanism involves specific IgG or IgE antibodies against TPO that activate mast cells or basophils, not just the presence of antibodies detected on routine thyroid testing. The antibodies are a marker of an autoimmune process affecting both thyroid and skin, rather than a direct causative agent.